Personalized Treatment for Refractory H Pylori Infection
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
In this study, the investigators develop a personalized treatment according to culture-guided
antibiotics plus high-dose proton-pump inhibitor and bismuth to treat refractory H pylori
infection.
Phase:
N/A
Details
Lead Sponsor:
Kaohsiung Veterans General Hospital.
Collaborator:
Kaohsiung Medical University Chung-Ho Memorial Hospital